Review article · 2020 · Open access

Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis

Pablo Andres Olivera, Juan S. Lasa, Stefanos Bonovas, Silvio Danese, Laurent Peyrin‐Biroulet

Gastroenterology, 158(6), 1554–1573.e12 · Published 8 January 2020 · DOI 10.1053/j.gastro.2020.01.001

Open PDFView at the publisherCite this paper

In brief

“Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis” is a 2020 review article by Pablo Andres Olivera and 4 co-authors, published in Gastroenterology. OpenAlex counts 362 citations as of 19 November 2026, which puts it in the top 1% of works published in 2020 by citations. It is open access: the full text is free to read at Gastroenterology.

Citations
362
Most cited in
2025 (66)
Field-weighted impact
6.87
References
109
Authors
5

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Olivera, P. A., Lasa, J. S., Bonovas, S., Danese, S., & Peyrin‐Biroulet, L. (2020). Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis. Gastroenterology, 158(6), 1554–1573.e12. https://doi.org/10.1053/j.gastro.2020.01.001

MLA 9

Olivera, Pablo Andres, et al. “Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis.” Gastroenterology, vol. 158, no. 6, 2020, pp. 1554–1573.e12. https://doi.org/10.1053/j.gastro.2020.01.001.

Chicago

Olivera, Pablo Andres, Juan S. Lasa, Stefanos Bonovas, Silvio Danese, and Laurent Peyrin‐Biroulet. 2020. “Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis.” Gastroenterology 158 (6): 1554–1573.e12. https://doi.org/10.1053/j.gastro.2020.01.001.

Harvard

Olivera, P. A. et al. (2020) ‘Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis’, Gastroenterology, 158(6), pp. 1554–1573.e12. doi:10.1053/j.gastro.2020.01.001.

IEEE

P. A. Olivera, J. S. Lasa, S. Bonovas, S. Danese, and L. Peyrin‐Biroulet, “Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis,” Gastroenterology, vol. 158, no. 6, pp. 1554–1573.e12, 2020, doi: 10.1053/j.gastro.2020.01.001.

BibTeX

@article{olivera2020safety,
  title     = {{Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis}},
  author    = {Olivera, Pablo Andres and Lasa, Juan S. and Bonovas, Stefanos and Danese, Silvio and Peyrin‐Biroulet, Laurent},
  journal   = {Gastroenterology},
  year      = {2020},
  volume    = {158},
  number    = {6},
  pages     = {1554--1573.e12},
  doi       = {10.1053/j.gastro.2020.01.001},
  url       = {https://doi.org/10.1053/j.gastro.2020.01.001}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20203939
20214848
20224747
20236262
20245151
20256666
20264949

Its field-weighted citation impact is 6.87: it has been cited 6.87 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies

  • JAK inhibitors
  • tofacitinib
  • upadacitinib
  • filgotinib
  • baricitinib
  • drug safety
  • adverse events
  • herpes zoster

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Olivera, P. A., Lasa, J. S., Bonovas, S., Danese, S., & Peyrin‐Biroulet, L. (2020). Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis. Gastroenterology, 158(6), 1554–1573.e12. https://doi.org/10.1053/j.gastro.2020.01.001

How many times has this paper been cited?

362 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Gastroenterology: sign in and open the PDF from this page.

Who wrote this paper?

Pablo Andres Olivera, Juan S. Lasa, Stefanos Bonovas, Silvio Danese, Laurent Peyrin‐Biroulet.

What is the DOI of this paper?

10.1053/j.gastro.2020.01.001, permanently at https://doi.org/10.1053/j.gastro.2020.01.001. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.